-
Mashup Score: 1
These therapies represent an encouraging advancement in cardiovascular care.
Source: www.pharmacytimes.comCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 0Add-On to GLP-1s Yields Greater Weight Loss - 7 month(s) ago
Those who received bupropion/naltrexone with GLP-1 therapy lost about 5% of body weight.
Source: www.mdedge.comCategories: General Medicine News, General HCPsTweet-
📢 Adding bupropion/naltrexone to #GLP-1 receptor agonists boosts total body weight loss by 4%-5% in patients with #obesity. https://t.co/rVNeGtWZFV https://t.co/X1qpYG3vNG
-
#GLP-1 receptor agonists such as semaglutide have shown potential to reduce the risk of heart failure in patients with #obesity related HF with preserved ejection fraction by improving weight and cardiovascular function. Learn more: https://t.co/EoIahFYhLH